Evidence map›Paper›PMID 29659618›Full record

ArticlePloS one2018

Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5.

YongMing Chen, XinYu Liu, FaBiao Zhang, ShanFan Liao, XiYuan He, DeXiang Zhuo, HuaiBin Huang, YongYang Wu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Immunohistochemical Analysis of pH-Sensitive TRPV5 in Common Skin Tumors.International journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Mitochondrial potassium channels: A novel calcitriol target.Cellular & molecular biology letters · 2022
    Article
  11. Article
  12. American journal of cancer research · 2022
    Article
  13. Article
  14. Observational
  15. Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

YongMing ChenDepartment of Urology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, Fujian, China.
XinYu LiuState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, China.
FaBiao ZhangDepartment of Urology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, Fujian, China.
ShanFan LiaoDepartment of Urology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, Fujian, China.
XiYuan HeDepartment of Urology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, Fujian, China.
DeXiang ZhuoDepartment of Urology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, Fujian, China.
HuaiBin HuangDepartment of Urology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, Fujian, China.
YongYang WuDepartment of Urology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, Fujian, China.ORCID 0000-0001-5212-6033
Fujian Medical University · CNSichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously demonstrated that transient receptor potential vanilloid subfamily 5 (TRPV5) expression was decreased in renal cell carcinoma (RCC) compared with that in normal kidney tissues, a finding that was correlated with vitamin D receptor (VDR) expression, but further investigations is warranted. The aim of this study was to elucidate whether VDR could regulate the expression of TRPV5 and affect proliferation and metastasis in RCC. In this study, we used lentivirus to conduct the model of VDR overexpression and knockdown caki-1 and 786-O RCC cell lines in vitro. The results demonstrated that VDR overexpression significantly inhibited RCC cells proliferation, migration and invasion, and promoted apoptosis by the MTT, transwell cell migration/invasion and flow cytometry assays, respectively. However, VDR knockdown in RCC cells had the opposite effect. The RNA-sequence assay, which was assessed in caki-1 cells after VDR overexpression and knockdown, also indicated that significantly differentially expressed genes were associated with cell apoptotic, differentiation, proliferation and migration. RT-PCR and western blot analysis showed that VDR knockdown increased TRPV5 expression and VDR overexpression decreased TRPV5 expression in caki-1 cells. Furthermore, knockdown of TRPV5 expression suppressed the VDR knockdown-induced change in the proliferation, migration and invasion in caki-1 cells. Taken together, these findings confirmed that VDR functions as a tumour suppressor in RCC cells and suppresses the proliferation, migration and invasion of RCC through regulating the expression of TRPV5.

Indexed as

Gene Expression Regulation, NeoplasticApoptosisCarcinoma, Renal CellCell Line, TumorCell MovementCell ProliferationComputational BiologyGene Expression ProfilingGene Knockout TechniquesGenetic VectorsHumansKidney NeoplasmsLentivirusReceptors, CalcitriolTRPV Cation ChannelsReceptors, CalcitriolTRPV5 protein, humanTRPV Cation Channels

Identifiers

PMID29659618
PMCPMC5901920
OpenAlexW2801792634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.